$95M mega-round in hand, Elaine Sul­li­van sets out to build a Eu­ro­pean on­col­o­gy play­er

A trans-At­lantic in­vest­ment syn­di­cate that in­cludes Google has come to­geth­er to bankroll a Eu­ro­pean on­col­o­gy start­up with a $95 mil­lion mega-round. And the biotech, helmed by ex­pe­ri­enced phar­ma R&D ex­ec Elaine Sul­li­van, has al­ready lined up three de­vel­op­ment pro­grams with plans to add more in the very near fu­ture.

The big idea here has less to do with any one pro­gram and sci­en­tif­ic founder than it has to do with the con­ti­nen­tal-sized part­ner­ing as­pi­ra­tions at Car­rick Ther­a­peu­tics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.